FI933755A0 - Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater - Google Patents

Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater

Info

Publication number
FI933755A0
FI933755A0 FI933755A FI933755A FI933755A0 FI 933755 A0 FI933755 A0 FI 933755A0 FI 933755 A FI933755 A FI 933755A FI 933755 A FI933755 A FI 933755A FI 933755 A0 FI933755 A0 FI 933755A0
Authority
FI
Finland
Prior art keywords
dicarboxylater
framing
piperidine
trans
proof
Prior art date
Application number
FI933755A
Other languages
English (en)
Finnish (fi)
Other versions
FI933755A (fi
Inventor
Frank John Urban
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI933755A publication Critical patent/FI933755A/fi
Publication of FI933755A0 publication Critical patent/FI933755A0/fi
Priority to FI962768A priority Critical patent/FI962768A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI933755A 1991-02-27 1993-08-26 Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater FI933755A0 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI962768A FI962768A0 (fi) 1991-02-27 1996-07-05 N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksylaatteja

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66172691A 1991-02-27 1991-02-27
PCT/US1992/000029 WO1992015561A2 (en) 1991-02-27 1992-01-08 Process for preparing trans-piperidine-2,5-dicarboxylates

Publications (2)

Publication Number Publication Date
FI933755A FI933755A (fi) 1993-08-26
FI933755A0 true FI933755A0 (fi) 1993-08-26

Family

ID=24654845

Family Applications (2)

Application Number Title Priority Date Filing Date
FI933755A FI933755A0 (fi) 1991-02-27 1993-08-26 Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater
FI962768A FI962768A0 (fi) 1991-02-27 1996-07-05 N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksylaatteja

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI962768A FI962768A0 (fi) 1991-02-27 1996-07-05 N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksylaatteja

Country Status (13)

Country Link
US (2) US5326874A (de)
EP (2) EP0737683A1 (de)
JP (1) JPH0725736B2 (de)
AT (1) ATE150453T1 (de)
CA (2) CA2101252C (de)
DE (1) DE69218414T2 (de)
DK (1) DK0573464T3 (de)
ES (1) ES2099820T3 (de)
FI (2) FI933755A0 (de)
GR (1) GR3023381T3 (de)
IE (2) IE920599A1 (de)
PT (1) PT100159B (de)
WO (1) WO1992015561A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
MX9702350A (es) * 1994-09-30 1997-06-28 Pfizer Derivados 2,7-sustituidos de octahidro-1h-pirido (1,2-a) pirazina.
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
GB0001447D0 (en) 2000-01-21 2000-03-08 Novartis Ag Organic compounds
MXPA03004016A (es) 2000-11-08 2004-02-12 Syngenta Participations Ag Pirrolcarboxamidas y pirrolcarbotioamidas y sus usos agroquimicos.
EP4032892A4 (de) 2019-09-18 2023-10-18 Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. Camptothecin-derivat und konjugat davon
EP4434548A1 (de) 2021-11-15 2024-09-25 Systimmune, Inc. Bispezifisches antikörper-camptothecin-wirkstoffkonjugat und pharmazeutische verwendung davon
AU2022402061A1 (en) 2021-12-03 2024-07-11 Systimmune, Inc. Anti-human trop2 antibody-camptothecin drug conjugate and medical use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018767A (en) * 1975-05-22 1977-04-19 Bristol-Myers Company Anti-arrhythmic agents
US4401820A (en) * 1981-01-23 1983-08-30 Tanabe Seiyaku Co., Ltd. Process for racemizing optically active α-amino acids or a salt thereof
US4505911A (en) * 1983-10-13 1985-03-19 Mead Johnson & Company Isoindole diuretic derivatives, compositions and use
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines

Also Published As

Publication number Publication date
FI962768A (fi) 1996-07-05
FI933755A (fi) 1993-08-26
GR3023381T3 (en) 1997-08-29
CA2195622A1 (en) 1992-08-28
EP0737683A1 (de) 1996-10-16
ATE150453T1 (de) 1997-04-15
JPH0725736B2 (ja) 1995-03-22
WO1992015561A3 (en) 1993-01-07
WO1992015561A2 (en) 1992-09-17
JPH06500121A (ja) 1994-01-06
ES2099820T3 (es) 1997-06-01
US5489688A (en) 1996-02-06
EP0573464A1 (de) 1993-12-15
PT100159A (pt) 1993-05-31
IE970704A1 (en) 2000-02-23
CA2101252A1 (en) 1992-08-28
DE69218414D1 (de) 1997-04-24
EP0573464B1 (de) 1997-03-19
IE920599A1 (en) 1992-09-09
DE69218414T2 (de) 1998-01-22
FI962768A0 (fi) 1996-07-05
CA2101252C (en) 1998-02-17
PT100159B (pt) 1999-07-30
US5326874A (en) 1994-07-05
DK0573464T3 (da) 1997-09-01
CA2195622C (en) 1999-08-17

Similar Documents

Publication Publication Date Title
ES2088537T3 (es) Derivados de piranil cianoguanidina.
ES2101960T3 (es) Lactamas benzo-condensadas.
NL300241I1 (nl) Hydroxymethyl(methyleencyclopentyl)uurines en -pyrimidines.
DK0444659T3 (da) Farmaceutisk opløsning indeholdende derivater af FK 506
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
DK506587A (da) Imidderivater
SE9100920D0 (sv) New active compounds
FI902846A0 (fi) Nya 2,5-diaryl-tetrahydrofuraner och deras analoger som paf-antagonister.
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ES2129397T3 (es) Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.
FI933755A (fi) Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
FI892681A0 (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
DK316589A (da) Substituerede azacyclohexylderivater af rifamyciner
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
ATE147376T1 (de) Heterocyclische derivate
SE8800637D0 (sv) Intermediates and process for preparation of antihypercholesterolemic tetrazole compounds
FI914138A0 (fi) Laekemedel, vilka innehaoller substituerade 2-cyklohexenderivat och deras anvaendning vid vaord av sjukdomar.
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel